BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jouhadi Z, Odou MF, Zerimech F, Bousfiha AA, Mikou N, Porchet N, Crepin M, Najib J, Balduyck M. Alpha1 antitrypsin deficiency due to an homozygous PI* Null Q0Cairo mutation: Early onset of pulmonary manifestations and variability of clinical expression. Respir Med Case Rep 2018;24:58-62. [PMID: 29977761 DOI: 10.1016/j.rmcr.2018.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Lorincz R, Curiel DT. Advances in Alpha-1 Antitrypsin Gene Therapy. Am J Respir Cell Mol Biol 2020;63:560-70. [PMID: 32668173 DOI: 10.1165/rcmb.2020-0159PS] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
2 Foil KE. Variants of SERPINA1 and the increasing complexity of testing for alpha-1 antitrypsin deficiency. Ther Adv Chronic Dis 2021;12_suppl:20406223211015954. [PMID: 34408833 DOI: 10.1177/20406223211015954] [Cited by in F6Publishing: 2] [Reference Citation Analysis]